Mingue, Brenda .
HRN: 24-33-60 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2024
CEFUROXIME 1.5GM (VIAL)
02/02/2024
02/03/2024
İVT
1.5
Q8
Post CS
Checking Final Appropriateness
02/02/2024
CEFUROXIME 500MG (TAB)
02/02/2024
02/08/2024
IVT
500mg
Q8
Post Cs
Checking Final Appropriateness
02/02/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/02/2024
02/08/2024
IVT
500mg
Q8
Post CS
Checking Final Appropriateness